InsidersTradesSigma
Follow the CARLSMED, INC. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €1.9bn. The latest transaction was disclosed on 22 June 2026 (Attribution). Among the most active insiders: YOUNG PHILIP M. Every trade is openly available.
Analysts rate CARLSMED, INC. Strong Buy (bullish), based on 11 analysts. Average price target: US$56.64.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
CARLSMED, INC. is a company listed on the XNAS market. It specializes in developing innovative solutions in the healthcare sector.